Arimoclomol for treating Niemann-Pick disease Type C [ID1312]
In development
Reference number: GID-HST10037
Expected publication date: TBC
Please note that following on from advice received from the company this evaluation has been rescheduled. Therefore, we now anticipate that the evaluation will begin during early November 2021 when we will write to you about how you can get involved. The deadline for submissions is expected in approximately mid-Jan 2022.